<DOC>
	<DOC>NCT01505647</DOC>
	<brief_summary>This study will determine whether ZOSTAVAX™ made with an alternative manufacturing process [ZOSTAVAX™ (AMP)] is well tolerated and immunogenic, and has a comparable immune response to ZOSTAVAX™.</brief_summary>
	<brief_title>Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)</brief_title>
	<detailed_description />
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>No fever on day of vaccination History of varicella or residence in a VZVendemic area for ≥30 years Females of reproductive potential must have a negative pregnancy test and must agree to use acceptable methods of birth control History of hypersensitivity reaction to any vaccine component Prior receipt of any varicella or zoster vaccine Prior history of herpes zoster Have recently had another vaccination Pregnant or breastfeeding Use of immunosuppressive therapy Known or suspected immune dysfunction Concomitant antiviral therapy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>